Literature DB >> 19747625

Age-dependent expression of hephaestin in the brain of ceruloplasmin-deficient mice.

Rui Cui1, Xiang-Lin Duan, Gregory J Anderson, Ya-Tiao Qiao, Peng Yu, Zhong-Ming Qian, Kunihiro Yoshida, Shin'ichi Takeda, Pei Guo, Zhen-Ling Yang, Yan-Zhong Chang.   

Abstract

Aceruloplasminemia is an autosomal recessive disorder caused by mutations in the ceruloplasmin (CP) gene. It is characterized by iron accumulation in the brain and in visceral organs. However, little is known about the mechanism of iron transport in these regions. Adult CP null (CP(-/-)) mice show increased iron deposition in several regions of brain, such as the cerebellum and brainstem. In this study, we investigated the expression of the ceruloplasmin homolog hephaestin (Heph) in the brain of CP(-/-) mice as a function of age. In the cerebral cortex and caudate putamen of 80-week-old CP(-/-) mice, the expression of Heph increased significantly whilst iron levels remain normal [Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 2002;22(15):6578-6], indicating that Heph might compensate for the loss of CP. In contrast, the substantia nigra and cerebellum of 80-week-old CP(-/-) mice accumulate iron but do not express high levels or significant decrease of Heph, suggesting that Heph does not replace CP in these regions. These data suggest that Heph may compensate for the loss of CP in a region-specific manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747625     DOI: 10.1016/j.jtemb.2009.05.004

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  6 in total

Review 1.  Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Mol Life Sci       Date:  2014-10-30       Impact factor: 9.261

Review 2.  Multi-copper oxidases and human iron metabolism.

Authors:  Ganna Vashchenko; Ross T A MacGillivray
Journal:  Nutrients       Date:  2013-06-27       Impact factor: 5.717

Review 3.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Authors:  Sonia Levi; Dario Finazzi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

Review 4.  Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.

Authors:  C E Arber; A Li; H Houlden; S Wray
Journal:  Neuropathol Appl Neurobiol       Date:  2015-06-02       Impact factor: 8.090

Review 5.  The Aging of Iron Man.

Authors:  Azhaar Ashraf; Maryam Clark; Po-Wah So
Journal:  Front Aging Neurosci       Date:  2018-03-12       Impact factor: 5.750

Review 6.  Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Front Mol Neurosci       Date:  2015-07-14       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.